According to Genome Web, Exact Sciences closed a revolving loan for $15 million and a non-revolving loan for $25.6 million, intended for their new headquarters project.
Senzime was awarded a CE Mark for its OnZurf probe, a tool for gastrointestinal tract surgical procedures.
The European Medicines Agency issued a positive opinion on Takeda and TiGenix’s Cx601, a complex perianal fistulas treatment for adults with non-active/mildly active luminal Crohn’s disease.
More articles on gastroenterology:
Exact Sciences secures $40.6M in financing — 3 insights
GI leader to know: Dr. Philip Nagel of Gastroenterology & Internal Medicine Specialists
Stock market week-in-review for 5 large GI companies — Dec. 11-15
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.